RT50 50mg*10vials

Retatrutide RT50 50mg*10vials

Retatrutide is a triple-receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, representing the highest-specification metabolic research peptide in the retatrutide product line.

The 50mg single-vial specification delivers the maximum active ingredient concentration available. This flagship formulation is engineered for ultra-limited metabolic mechanism research, ultra-high-dose gradient efficacy validation, large-scale long-term preclinical projects, and extreme phenotypic modeling. The high concentration per vial eliminates repeated dilution steps across extended experimental timelines, reducing data deviation and sample contamination risk.

Dual GLP-1 and GIP pathway activation supports in-depth exploration of insulin sensitivity, glycemic regulation, and appetite-related signaling mechanisms. The glucagon receptor component adds energy expenditure and lipid metabolism pathways for comprehensive metabolic research coverage.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Every batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for top-tier professional research institutions and large-scale global procurement.